Treatment of cutaneous leishmaniasis with thermotherapy in Brazil: an efficacy and safety study
- PMID: 29924242
- PMCID: PMC6001097
- DOI: 10.1590/abd1806-4841.20186415
Treatment of cutaneous leishmaniasis with thermotherapy in Brazil: an efficacy and safety study
Abstract
Background: Pentavalent antimonials remain as the standard drugs in the treatment of cutaneous leishmaniosis. The high cost, difficult administration, long treatment time, toxicity and increasing morbidity are factors that limit the use of these drugs.
Objectives: To describe the response to radiofrequency thermotherapy in the treatment of localized cutaneous leishmaniasis in Brazil, and to evaluate its safety and tolerability.
Methods: We conducted a non-comparative open trial with a total of 15 patients confirmed to have cutaneous leishmaniasis on parasitological examination. A single radiofrequency thermotherapy session at 50ºC for 30 seconds was applied to the lesion and its edges. In patients with more than one lesion, only the largest one was treated initially. If after 30 days there was no evidence of healing, the smaller lesion was also treated with thermotherapy. Clinical cure was defined as visible healing for three months after treatment. The patients were followed-up for six months and there was no follow-up loss.
Results: Of all 23 lesions, only two evolved to complete healing without the need of treatment. Of 21 lesions, 18 (85.7%) achieved full healing. The main observed side effects were itching, burning sensation, pain and blisters.
Study limitations: Sample with a small number of patients and short follow-up.
Conclusion: Thermotherapy can be considered a therapeutic alternative in localized cutaneous leishmaniasis, especially in cases of single cutaneous lesions and with formal contraindications to conventional treatment with pentavalent antimonials.
Conflict of interest statement
Conflict of interest: None.
Figures



Similar articles
-
Thermotherapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia.Rev Inst Med Trop Sao Paulo. 2013;55(3):S0036-46652013000300197. doi: 10.1590/S0036-46652013000300011. Rev Inst Med Trop Sao Paulo. 2013. PMID: 23740007 Clinical Trial.
-
Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis.J Evid Based Med. 2017 May;10(2):81-90. doi: 10.1111/jebm.12245. J Evid Based Med. 2017. PMID: 28276641
-
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.Trials. 2012 May 17;13:58. doi: 10.1186/1745-6215-13-58. Trials. 2012. PMID: 22594858 Free PMC article. Clinical Trial.
-
Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.Drugs. 2013 Nov;73(17):1889-920. doi: 10.1007/s40265-013-0132-1. Drugs. 2013. PMID: 24170665 Review.
-
A Therapeutic update on Cutaneous leishmaniasis.J Coll Physicians Surg Pak. 2003 Aug;13(8):471-6. J Coll Physicians Surg Pak. 2003. PMID: 12921689 Review.
Cited by
-
Cutaneous leishmaniasis control in Alta Verapaz (northern Guatemala): evaluating current efforts through stakeholders' experiences.Infect Dis Poverty. 2021 May 7;10(1):61. doi: 10.1186/s40249-021-00842-3. Infect Dis Poverty. 2021. PMID: 33962699 Free PMC article.
-
Review of Leishmaniasis Treatment: Can We See the Forest through the Trees?Pharmacy (Basel). 2024 Feb 8;12(1):30. doi: 10.3390/pharmacy12010030. Pharmacy (Basel). 2024. PMID: 38392937 Free PMC article. Review.
-
A Review of Leishmaniasis: Current Knowledge and Future Directions.Curr Trop Med Rep. 2021;8(2):121-132. doi: 10.1007/s40475-021-00232-7. Epub 2021 Mar 17. Curr Trop Med Rep. 2021. PMID: 33747716 Free PMC article. Review.
-
Molecular characteristic of treatment failure clinical isolates of Leishmania major.PeerJ. 2021 Mar 11;9:e10969. doi: 10.7717/peerj.10969. eCollection 2021. PeerJ. 2021. PMID: 33763300 Free PMC article.
-
An overview of the treatment of cutaneous leishmaniasis.Fac Rev. 2020 Dec 22;9:28. doi: 10.12703/r/9-28. eCollection 2020. Fac Rev. 2020. PMID: 33659960 Free PMC article. Review.
References
-
- World Health Organization (WHO) Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. Geneva: World Health Organization; - 2010. Mar,
-
- Brasil. Secretaria de Vigilância em Saúde . Manual de Vigilância da Leishmaniose Tegumentar Americana. 2 ed. rev. atual. Brasília: Ministério da Saúde; 2010.
-
- Saude.gov.br [Internet] Sistema Nacional de Vigilância em Saúde: Relatório de Situação. Piaui: [27 jun 2016]. Disponível em: http://portal.saude.gov.br/svs/leishmaniosetegumentaramericana.
-
- Mashayekhi-Ghoyonlo V, Kiafar B, Rohani M, Esmaeili H, Erfanian-Taghvaee MR. Correlation between Socioeconomic Status and Clinical Course in Patients with Cutaneous Leishmaniasis. J Cutan Med Surg. 2015;19:40–44. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources